National trends in neoadjuvant systemic therapy utilization in patients with early-stage HER2-positive breast cancer from 2016–2021: The impact of the KATHERINE trial.
- Published in:
- Breast Cancer Research & Treatment, 2025, v. 212, n. 3, p. 531, doi. 10.1007/s10549-025-07750-2
- By:
- Publication type:
- Article